A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PS / protamine sulfate

[Related PubMed/MEDLINE]
Total Number of Papers: 126
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PS  (>> Co-occurring Abbreviation)
Long Form:   protamine sulfate
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Assessing bladder hyper-permeability biomarkers in vivo using molecularly-targeted MRI. GAG, HRP, IC/BPS, mt-MRI, mt-MRI, VEGFR1, ZO-1
2020 Chondroitin sulfate and its nanocomposites with protamine or chitosan stabilize and deliver available nanosized iron. ChS, CS, FeONPs
2020 Facile Strategy To Enhance Specificity and Sensitivity of Molecular Beacons by an Aptamer-Functionalized Delivery Vector. ACMC, ANP, MBs
2020 Layered double hydroxide-based antioxidant dispersions with high colloidal and functional stability. EA, LDH, PAAm-co-DADMAC, PEI
2020 Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells. AGEs, DN, ECM, ESRD, FN, HRMC, LMWF, MCs, SPR
2020 Protamine sulphate coated poly (lactide-co-glycolide) nanoparticles of MUC-1 peptide improved cellular uptake and cytokine release in mouse antigen presenting cells. APCs, CU, M-1-pep
2019 Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model. DOCA, FSGS, TRP, TRPC5
2019 Optimization of lentiviral transduction parameters and its application for CRISPR-based secretome modification of human endometrial mesenchymal stem cells. CRISPR, hMESCs, MSCs, PB
2019 Protamine Sulfate Induces Mitochondrial Hyperpolarization and a Subsequent Increase in Reactive Oxygen Species Production. CytOx, ROS
10  2019 Self-assembled nanovehicle-mediated co-encapsulation of inactivated EV71 virus and CpG oligonucleotides elicits potent anti-EV71 humoral and cellular immune protective responses. CMG, EV71, NP, ODN
11  2019 The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents. UFH
12  2018 A new chemical complex can rapidly concentrate lentivirus and significantly enhance gene transduction. CSC, HEK293T, mMSC, PB, PEG
13  2018 A novel therapeutics agent: antioxidant effects of hydroxylfasudil on rat kidney and liver tissues in a protamine sulphate-induced cystitis rat model; preliminary results. CAT, HF, LPO, SOD
14  2018 Development of methods for data quantitation of spiked salmon host cell DNA in protamine sulfate by qPCR. LLOQ, resDNA
15  2018 Linaclotide Attenuates Visceral Organ Crosstalk: Role of Guanylate Cyclase-C Activation in Reversing Bladder-Colon Cross-Sensitization. BPS, CRD, GCC, IBS, IBS-C, TEER
16  2018 Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability. ---
17  2018 Quantitation of residual host cell DNA in protaminesulfate drug product by qPCR. LLOQ, qPCR, resDNA
18  2017 Active nano/microbilayer hemostatic agents for diabetic rat bleeding model. BC, CTS, KAO, PC, SF, Vit K
19  2016 In the absence of overt urothelial damage, chondroitinase ABC digestion of the GAG layer increases bladder permeability in ovariectomized female rats. ChABC, GAG
20  2016 Preparation and evaluation a new generation of low molecular weight heparin. NG-LMWH
21  2016 The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis. BPS/IC, IC, JNK
22  2015 Comparative Biochemical and Proteomic Analyses of Soybean Seed Cultivars Differing in Protein and Oil Content. 2DGE
23  2015 Degradable hyaluronic acid/protamine sulfate interpolyelectrolyte complexes as miRNA-delivery nanocapsules for triple-negative breast cancer therapy. HA, miR-34a
24  2015 Depletion of RuBisCO protein using the protamine sulfate precipitation method. HAP, LAP, RuBisCO
25  2015 Diazeniumdiolation of protamine sulfate reverses mitogenic effects on smooth muscle cells and fibroblasts. ROS
26  2015 Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model. ---
27  2015 Impact of Rho-Kinase Inhibitor Hydroxyfasudil in Protamine Sulphate Induced Cystitis Rat Bladder. BO
28  2015 New synthetic peptide with efficacy for heparin reversal and low toxicity and immunogenicity in comparison to protamine sulfate. APTT, UFH
29  2015 Protamine sulfate precipitation method depletes abundant plant seed-storage proteins: A case study on legume plants. PSP, RuBisCO, SSPs
30  2014 Dynamic, size-selective effects of protamine sulfate and hyaluronidase on the rat glomerular filtration barrier in vivo. GFB
31  2014 Mast cell activation and response to tolterodine in the rat urinary bladder in a chronic model of intravesical protamine sulfate and bacterial endotoxin-induced cystitis. DO, IC, LPS, OAB
32  2014 Sustainable DNA release from chitosan/protein based-DNA gel particles. CL
33  2014 Using protamine can significantly reduce the incidence of bleeding complications after carotid endarterectomy without increasing the risk of ischemic cerebral events. CEA
34  2013 Dual ionic interaction system based on polyelectrolyte complex and ionic, injectable, and thermosensitive hydrogel for sustained release of human growth hormone. AUC, hGH, PEC
35  2013 pH-responsive biodegradable assemblies containing tunable phenyl-substituted vinyl ethers for use as efficient gene delivery vehicles. DOPE, PEG, PEI, PIVE
36  2013 Protamine sulfate-nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells. ---
37  2013 Tumour cell labelling by magnetic nanoparticles with determination of intracellular iron content and spatial distribution of the intracellular iron. MFM, SPIO, SPIONs
38  2012 Glioma cell growth inhibition following photochemical internalization enhanced non-viral PTEN gene transfection. BPEI, PCI, PTEN
39  2012 Microcapsules with intrinsic barium radiopacity for immunoprotection and X-ray/CT imaging of pancreatic islet cells. APLLA, CT
40  2011 Anti-biofilm and anti-adherence activity of Glm-U inhibitors. CRBSI, CVCs, NEM, UDP-GlcNAc
41  2011 Cationic derivatives of dextran and hydroxypropylcellulose as novel potential heparin antagonists. DEX, HPC, UFH
42  2011 Effect of indometacin pretreatment on protamine sulfate-mediated relaxation of the isolated rat uterus: the role of the antioxidative defense system. NO
43  2011 Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder. GAG, MDA, ML, RR
44  2011 Phosphorylation of podocalyxin (Ser415) Prevents RhoA and ezrin activation and disrupts its interaction with the actin cytoskeleton. PAN, PC, S415E
45  2011 Polyamine/DNA polyplexes with acid-degradable polymeric shell as structurally and functionally virus-mimicking nonviral vectors. PK, Spm
46  2010 "Intelligent" nanoassembly for gene delivery: in vitro transfection and the possible mechanism. DOPE, INA, PSD
47  2010 Chitosan derivatives as novel potential heparin reversal agents. CH, HTCC, LMWH, UFH
48  2010 Development of nanosomes using high-pressure homogenization for gene therapy. HPH
49  2010 The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model. BNAs, FNA, HCC, nFNAs
50  2009 Effects of protamine sulphate on spontaneous and calcium-induced contractile activity in the rat uterus are potassium channels-mediated. 4-AP, L-NAME, MB, TEA
51  2009 Protamine sulfate/poly(L-aspartic acid) polyionic complexes self-assembled via electrostatic attractions for combined delivery of drug and gene. DOX, DOX-PICs, GFP, PASP, PEI, PICs, TEM
52  2009 Rapid and efficient cell labeling with a MRI contrast agent by electroporation in the presence of protamine sulfate. ---
53  2008 A smart nanoassembly consisting of acid-labile vinyl ether PEG-DOPE and protamine for gene delivery: preparation and in vitro transfection. DOPE, PVD, SNA
54  2008 Activity of different phospholipids in attenuating hyperactivity in bladder irritation. BCF, CMGs
55  2008 Claudin-6 localized in tight junctions of rat podocytes. ---
56  2008 Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens. CHX
57  2008 Long-lasting breaches in the bladder epithelium lead to storage dysfunction with increase in bladder PGE2 levels in the rat. UF
58  2008 Prophylactic role of oral L-arginine on histological and contractile changes in a rat chronic bladder injury model. EFS
59  2008 Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. CAT, UFH
60  2007 A multifunctional nano device as non-viral vector for gene delivery: in vitro characteristics and transfection. CMND, DOPE, MND
61  2007 Corneal epithelium as a platform for secretion of transgene products after transfection with liposomal gene eyedrops. HCE, Luc, PEI, SEAP
62  2007 Effect of ovotransferrin, protamine sulfate and EDTA combination on biofilm formation by catheter-associated bacteria. EDTA, GRAS, OT
63  2007 In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. ELP, mESC, PLL, SCs
64  2007 Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen. HA, IFN-gamma
65  2006 Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens. GlmU, IDA, NEM, PyrM
66  2006 Aqueous garlic extract inhibits protamine sulfate-induced bladder damage. AGE, MDA
67  2006 Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro. GAGs, IGFBPs, nac
68  2006 Protective effects of taurine on protamine sulfate induced bladder damage. MDA
69  2005 In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. BTX-A, CMG, SCI, SCI
70  2005 Long-lasting secretion of transgene product from differentiated and filter-grown retinal pigment epithelial cells after nonviral gene transfer. RPE, SEAP
71  2005 Polycations enhance emulsion-mediated in vitro and in vivo transfection. EtBr, LE, LP
72  2004 Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood-brain barrier is differentially regulated. BBB, HIV
73  2003 Coxsackievirus and adenovirus receptor, a tight junction membrane protein, is expressed in glomerular podocytes in the kidney. CAR, PAN
74  2003 Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity. CMGs
75  2003 Small increases in pH enhance retroviral vector transduction efficiency of NIH-3T3 cells. MMLV, MSCV, PB
76  2002 Bladder permeability barrier: recovery from selective injury of surface epithelial cells. ---
77  2002 Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition. DC
78  2001 Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88). ACT, APTT, ATIII, ECT, HCII, PF4, PT, TEG, TFPI, TT
79  2001 Intravesical ethanol as quantitative measure of bladder hyperpermeability. GAG, IC
80  2001 Methods for determination of milt protein and epsilon-polylysine in food additive preparations and processed foods by capillary zone electrophoresis. CZE, MP, PL
81  2000 Nuclear transport of oligonucleotides in HepG2-cells mediated by protamine sulfate and negatively charged liposomes. CLSM, ON
82  2000 Regulation of mouse podocyte process dynamics by protein tyrosine phosphatases rapid communication. ECM, PA, PTPs, RT-PCR
83  2000 Urothelial cytoprotective activity of Tamm-Horsfall protein isolated from the urine of healthy subjects and patients with interstitial cystitis. IC, THP
84  2000 [Molecular dynamics of proteins found exclusively in glomerular epithelial cells]. PAN, TJ
85  2000 [Prevention of negative hemodynamic effects of protamine sulfate by simultaneous infusion of microdoses of adrenaline]. ---
86  1999 Relationship of protamine dosing with postoperative complications of carotid endarterectomy. CEA, Hep
87  1997 Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4. APTT, DHG, LMWH, PF4, TCT, UFH
88  1997 The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man. AT, DVT, FXa, LMWH, s.c, TF-FVIIa, TFPI
89  1996 Bladder injury model induced in rats by exposure to protamine sulfate followed by bacterial endotoxin. LPS, UBM
90  1995 Immunocytochemical studies of protamine-induced blood-brain barrier opening to endogenous albumin. BBB, PB
91  1995 Increased Tyr phosphorylation of ZO-1 during modification of tight junctions between glomerular foot processes. pTyr
92  1994 A new method for cytodestruction of bladder epithelium using protamine sulfate and urea. GAG
93  1994 Evaluation of recombinant platelet factor 4 and protamine sulfate for heparin neutralization: clotting and clearance studies in rat. ASBA, rPF4
94  1994 Inhibition of in vitro calcium phosphate precipitation in presence of polyurethane via surface modification and drug delivery. EPC
95  1994 Interstitial activated (IL-2R+) mononuclear cells and Ia antigens in experimental focal glomerulosclerosis. AN, FGS, MHC, PSL
96  1994 Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteers. anti-Xa, BW, i.v, LMWH, s.c, UH
97  1994 Protamine sulfate and vancomycin are synergistic against Staphylococcus epidermidis prosthesis infection in vivo. ---
98  1993 Complete saturation of protamine sulphate by dsDNA is necessary in order to obtain a highly sensitive and specific anti-dsDNA ELISA. OAID
99  1993 Modification of epithelial permeability by cationic polypeptides. ---
100  1992 Determination of soluble fibrin: a comparison of four different methods. SF, SF-EAT, tPA